RARE Institutional Ownership & Shareholders

ULTRAGENYX PHARMACEUTICAL IN (RARE) is currently held by 298 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $3.45B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of RARE tracked by InsiderSet, reporting ownership valued at approximately $355.75M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $177.18M, representing an estimated loss of -50.19% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 53% of the total disclosed RARE value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Rtw Investments, Lp, Vanguard Portfolio Management Llc, and several other long-term asset managers with concentrated positions in ULTRAGENYX PHARMACEUTICAL IN (RARE).

This page ranks the largest institutional RARE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

298

Total Reported Value

$3.45B

Largest Holder

Blackrock, Inc.

Largest Position

$355.75M

Insider Transactions (90d)

3

Latest Filing Quarter

Q2 2026

New Institutional Positions

58

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.01%10,654,276$355,746,262$177,180,610-$178,565,652-50.19%
Rtw Investments, Lp2.22%7,796,895$260,338,324$129,662,364-$130,675,960-50.19%
Vanguard Portfolio Management Llc0.01%6,790,135$226,722,608$112,919,945-$113,802,663-50.19%
Aqr Capital Management Llc0.07%6,560,809$214,144,806$109,106,254-$105,038,552-49.05%
State Street Corp0.01%6,158,766$205,641,197$102,420,279-$103,220,918-50.19%
Vanguard Capital Management Llc0.00%4,296,491$143,459,834$71,450,645-$72,009,189-50.19%
Two Sigma Investments, Lp0.09%3,621,200$120,911,868$60,220,556-$60,691,312-50.19%
Sands Capital Management, Llc0.39%3,158,368$105,457,908$52,523,660-$52,934,248-50.19%
Jacobs Levy Equity Management, Inc0.35%2,939,719$98,157,217$48,887,527-$49,269,690-50.19%
Frontier Capital Management Co Llc0.89%2,847,936$95,092,590$47,361,176-$47,731,414-50.19%
Geode Capital Management, Llc0.00%2,578,828$86,123,888$42,885,910-$43,237,978-50.20%
Bellevue Group Ag1.39%1,982,775$66,204,857$32,973,548-$33,231,309-50.19%
D. E. Shaw & Co., Inc.0.04%1,730,193$57,771,145$28,773,110-$28,998,035-50.19%
Sofinnova Investments, Inc.3.06%1,717,505$57,347,492$28,562,108-$28,785,384-50.19%
Adage Capital Partners Gp, L.L.C.0.07%1,580,000$52,756,200$26,275,400-$26,480,800-50.19%
Gw&K Investment Management, Llc0.39%1,481,178$49,457,000$24,631,990-$24,825,010-50.20%
Mpm Bioimpact Llc2.89%1,418,215$47,354,199$23,584,915-$23,769,284-50.19%
Price T Rowe Associates Inc0.00%1,356,501$45,295,000$22,558,612-$22,736,388-50.20%
Morgan Stanley0.00%1,324,805$44,235,265$22,031,507-$22,203,758-50.19%
Wellington Management Group Llp0.01%1,250,464$41,752,993$20,795,216-$20,957,777-50.19%
Voloridge Investment Management, Llc0.18%1,241,556$41,455,555$20,647,076-$20,808,479-50.19%
Bank Of America Corp0.00%1,148,454$38,346,863$19,098,790-$19,248,073-50.19%
Rock Springs Capital Management Lp1.58%967,855$32,316,678$16,095,429-$16,221,249-50.19%
Jefferies Financial Group Inc.0.29%929,626$31,040,212$15,459,680-$15,580,532-50.19%
Northern Trust Corp0.00%920,314$30,729,285$15,304,822-$15,424,463-50.19%
Eagle Health Investments Lp4.89%884,121$29,520,800$14,702,932-$14,817,868-50.19%
Qube Research & Technologies Ltd0.03%882,219$29,457,292$14,671,302-$14,785,990-50.19%
Russell Investments Group, Ltd.0.02%784,099$26,181,069$13,039,566-$13,141,503-50.19%
Millennium Management Llc0.02%760,825$25,403,947$12,652,520-$12,751,427-50.19%
Charles Schwab Investment Management Inc0.00%760,039$25,377,702$12,639,449-$12,738,253-50.19%
Nuveen, Llc0.01%693,959$23,171,291$11,540,538-$11,630,753-50.19%
Vanguard Fiduciary Trust Co0.00%671,411$22,418,413$11,165,565-$11,252,848-50.19%
Ubs Group Ag0.00%657,699$21,960,569$10,937,534-$11,023,035-50.19%
Palo Alto Investors Lp2.75%596,495$19,916,968$9,919,712-$9,997,256-50.19%
Sphera Funds Management Ltd.2.81%588,494$19,649,815$9,786,655-$9,863,160-50.19%
Legal & General Group Plc0.00%586,520$19,583,902$9,753,828-$9,830,074-50.19%
Panagora Asset Management Inc0.06%586,230$19,574,220$9,749,005-$9,825,215-50.19%
Fmr Llc0.00%576,849$19,260,990$9,592,999-$9,667,991-50.19%
Goldman Sachs Group Inc0.00%575,338$19,210,535$9,567,871-$9,642,664-50.19%
Trexquant Investment Lp0.11%556,385$18,577,695$9,252,683-$9,325,012-50.19%
Bnp Paribas Financial Markets0.01%498,167$16,633,796$8,284,517-$8,349,279-50.19%
Bank Of New York Mellon Corp0.00%470,697$15,716,566$7,827,691-$7,888,875-50.19%
Jpmorgan Chase & Co0.00%493,126$15,268,024$8,200,685-$7,067,339-46.29%
Toronto Dominion Bank0.02%415,000$13,856,850$6,901,450-$6,955,400-50.19%
Renaissance Technologies LLCJim Simons0.02%413,700$13,813,443$6,879,831-$6,933,612-50.19%
Bnp Paribas Asset Management Holding S.A.0.01%409,255$13,665,024$6,805,911-$6,859,113-50.19%
Krensavage Asset Management, Llc4.96%390,879$13,051,000$6,500,318-$6,550,682-50.19%
Algert Global Llc0.15%389,964$13,020,898$6,485,101-$6,535,797-50.19%
Manufacturers Life Insurance Company, The0.01%381,420$12,735,614$6,343,015-$6,392,599-50.19%
Summittx Capital, L.P.0.33%374,270$12,496,875$6,224,110-$6,272,765-50.19%
Showing 50 of 298

Frequently asked questions about RARE

  • Who are the largest institutional holders of RARE?

    The largest institutional holders of RARE reported in the latest SEC Form 13F filings include Blackrock, Inc., Rtw Investments, Lp, Vanguard Portfolio Management Llc, Aqr Capital Management Llc, and State Street Corp. InsiderSet ranks institutional holders by their latest reported RARE position.

  • What is RARE institutional ownership?

    This page tracks RARE positions reported by institutional investment managers through SEC Form 13F. ULTRAGENYX PHARMACEUTICAL IN (RARE) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own RARE?

    InsiderSet currently tracks 298 institutional managers reporting RARE holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of RARE shareholders.

  • How much RARE stock do institutions own?

    Institutional investment managers disclosed approximately $3.45B in RARE holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was RARE institutional ownership last updated?

    The latest RARE institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional RARE holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its RARE position after the reporting date.

  • Are institutions buying or selling RARE?

    Institutional buying and selling can be analyzed by comparing RARE positions across consecutive 13F reporting periods. InsiderSet's RARE Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View RARE ownership changes.

  • How has RARE institutional ownership changed over time?

    InsiderSet tracks RARE institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.